Adverse effects and acceptability of contraceptive subdermal implantation in panamanian adolescents and young adults 2017 – 2020
Authors
DOI:
https://doi.org/10.37980/im.journal.revcog.20242482Keywords:
subdermal implant, adverse effects, contraceptives, adolescentsAbstract
OBJECTIVE: To describe the adverse effects and acceptability of Implanon in patients under 24 years of age. METHODOLOGY: Prospective descriptive study of 98 women consecutively recruited. The Epi Info version 7 program was used. Those under 18 years of age were attended by assent. Patients with contraindications were excluded. RESULTS: The mean age was 19.6 years, 47.4% adolescents and 52.5% young adults. 85.7% had the onset of sexual life between 15 and 19 years of age. The alterations more frequent were changes in bleeding patterns. There was a significant difference between those who were postpartum and those who had not had recent births. In addition, a patient with a medical history of schizophrenia had periods of increased aggression during the first six months of implant use. Weight gain occurred in 26% of patients. Nine patients had the implant removed. There were no pregnancies. CONCLUSIONS: There was a great acceptance of women who used Implanon. This was due to the strict follow-up and control during the study and at the same time, bleeding was reduced in quantity and time, achieving a low percentage of withdrawal before three years.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Infomedic Intl.Derechos autoriales y de reproducibilidad. La Revista RevCog es un ente académico, sin fines de lucro, que forma parte de la Sociedad Centroamericana de Ginecología y Obstetricia. Sus publicaciones son de tipo ACCESO GRATUITO y PERMANENTE de su contenido para uso individual y académico, sin restricción. Los derechos autoriales de cada artículo son retenidos por sus autores. Al Publicar en la Revista, el autor otorga Licencia permanente, exclusiva, e irrevocable a la Sociedad para la edición del manuscrito, y otorga a la empresa editorial, Infomedic International Licencia de uso de distribución, indexación y comercial exclusiva, permanente e irrevocable de su contenido y para la generación de productos y servicios derivados del mismo.